Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
Chronic Obstructive Pulmonary Disease
|
NIMH
|
1R01MH076829-01A1
|
|
Treating Older Patients with Major Depression and Severe COPD
|
ALEXOPOULOS, GEORGE
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$353,058
|
Chronic Obstructive Pulmonary Disease
|
NINR
|
5R01NR008938-03
|
|
Dyspnea Self-Management: Internet or Face-to-Face
|
CARRIERI-KOHLMAN, VIRGINIA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$467,706
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL089438-01
|
|
Genetic Features of Gender Differences in COPD
|
DEMEO, DAWN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$840,766
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL084225-02
|
|
Genetic Factors Controlling Effector Function of TGF-beta in COPD and Fibrosis
|
LEE, CHUN
|
YALE UNIVERSITY
|
CT
|
$413,020
|
Chronic Obstructive Pulmonary Disease
|
NIEHS
|
5K22ES014742-02
|
|
Mechanisms of Asbestos-Induced CIca1 and Mucin in Lung Epithelium
|
SABO-ATTWOOD, TARA
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$105,039
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL073373-04
|
|
The Genetic Epidemiology of COPD in Costa Rica
|
CELEDON, JUAN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$751,445
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R21HL091237-01
|
|
Dyspnea Outcome Instrument for COPD Research
|
NORWEG, ANNA
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$209,769
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL086936-02
|
|
Smoke Induced Airway Injury in COPD
|
D'ARMIENTO, JEANINE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$394,172
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL088572-01A1
|
|
Elastase Injury of Pulmonary Extracellular Matrix
|
NUGENT, MATTHEW
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$406,250
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL084331-01A2
|
|
CT Diagnosis of Tracheomalacia in Patients with COPD
|
BOISELLE, PHILLIP
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$390,689
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL088325-01A1
|
|
Role of the Aryl Hydrocarbon Receptor in Lung Inflammation
|
SIME, PATRICIA
|
UNIVERSITY OF ROCHESTER
|
NY
|
$385,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R37HL053949-14
|
|
In Vivo Function of Pulmonary Integrins
|
SHEPPARD, DEAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$359,123
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL088138-01A1
|
|
Apoptosis and defective repair in COPD
|
HENSON, PETER
|
NATIONAL JEWISH HEALTH
|
CO
|
$708,315
|
Chronic Obstructive Pulmonary Disease
|
NCI
|
1R01CA127219-01A1
|
|
Inflammation Genes and Lung Cancer Risk
|
SPITZ, MARGARET
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$549,712
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL088608-01A1
|
|
Neurotrophin Regulation of the Airway Parasympathetic Nervous System
|
MYERS, ALLEN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$410,000
|
Chronic Obstructive Pulmonary Disease
|
NIAID
|
2R01AI019641-23A1
|
|
Pathogenesis of Haemophilus influenzae infection in COPD
|
MURPHY, TIMOTHY
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$313,189
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL077783-03
|
|
A New Pathway for Neutrophil-induced Airway Inflammation
|
BLALOCK, J
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$353,201
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL075476-05
|
|
Fish Oil Intake, Biomarkers and Change in Lung Function
|
BARR, R
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$376,582
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL083893-03
|
|
H. influenzae genes associated with COPD
|
GILSDORF, JANET
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$368,980
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL084469-01A2
|
|
Adaptive glutathione responses to cigarette smoke in COPD
|
DAY, BRIAN
|
NATIONAL JEWISH HEALTH
|
CO
|
$389,160
|
Chronic Obstructive Pulmonary Disease
|
NIA
|
1K08AG030235-01A2
|
|
Diet, Biomarkers and Lung Function
|
JIANG, RUI
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$124,560
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R21HL087805-01A1
|
|
Quantitative MRI-based Assessment of Aerosol Deposition in the Lung
|
DARQUENNE, CHANTAL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$188,870
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL083844-03
|
|
THE ROLE OF PNEUMOCYSTIS IN THE DEVELOPMENT OF COPD
|
CHRISTENSEN, PAUL
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$305,865
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL064741-05
|
|
Assessment of lung function in small animals
|
RIZI, RAHIM
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$393,750
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL066548-06
|
|
MNEI/SerpinB1: A modulator of innate pulmonary defense
|
REMOLD-O'DONNELL, EILEEN
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$473,500
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL085096-02
|
|
Computerized Classification of COPD and Contributing Components
|
LEADER, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$322,614
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL063993-07
|
|
Integrin alphavbeta8 Inhibits Airway Epithelial Cell Growth
|
NISHIMURA, STEPHEN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$346,781
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R43HL091688-01
|
|
Therapeutic Potential of a Small Molecule Compound for Emphysema
|
OEHLEN, BERT
|
ANGION BIOMEDICA CORPORATION
|
NY
|
$234,658
|
Chronic Obstructive Pulmonary Disease
|
NINR
|
5R01NR010006-02
|
|
Investigation of the Affective Dimension of Dyspnea
|
BANZETT, ROBERT
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$508,232
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL059215-10
|
|
Mechanisms of Progression in Late Stage Emphysema
|
SUKI, BELA
|
BOSTON UNIVERSITY
|
MA
|
$355,022
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL056309-11
|
|
Apoptotic T Cell Clearance From Murine Lungs
|
CURTIS, JEFFREY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$283,500
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL085469-02
|
|
The Molecular Basis of Serpin Function and Disfunction
|
WINTRODE, PATRICK
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$309,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R37HL067204-08
|
|
Role of Elastolytic Cathepsins in Emphysema
|
CHAPMAN, HAROLD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$428,082
|
Chronic Obstructive Pulmonary Disease
|
NCI
|
5R01CA080127-08
|
|
Alpha-1 AD Carriers and Lung Cancer Risk
|
YANG, PING
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$524,374
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL077618-05
|
|
Disability and Health Outcomes in COPD
|
EISNER, MARK
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$504,153
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL089399-02
|
|
Mucociliary Function in Chronic Bronchitis
|
SALATHE, MATTHIAS
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$382,500
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL083482-04
|
|
Pathogenesis of HIV-Related Emphysema: T Cells, smoking*
|
BECK, JAMES
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$325,585
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL083462-04
|
|
Pneumocystis and COPD in a Simian Model of AIDS
|
NORRIS, KAREN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$370,197
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL083461-05
|
|
Pneumocystis in Pathogenesis of HIV-associated Emphysema
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$385,257
|
Chronic Obstructive Pulmonary Disease
|
NINR
|
1K01NR010749-01
|
|
Nurse Managed Cognitive Behavioral Therapy for Insomnia in People with COPD
|
KAPELLA, MARY
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$95,420
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL083478-04
|
|
Alveolar macrophage proteomics in HIV-induced emphysema
|
DIAZ, PHILIP
|
OHIO STATE UNIVERSITY
|
OH
|
$389,820
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL037784-23
|
|
Local Expression of Alpha-1-Antitrypsin in Emphysema
|
PERLMUTTER, DAVID
|
CHILDREN'S HOSP PITTSBURGH/UPMC HLTH SYS
|
PA
|
$340,160
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL081205-04
|
|
Modifier Role of Nrf2 in Lung Injury and Emphysema
|
BISWAL, SHYAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$388,754
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL077328-03
|
|
Ceramide-induced lung destruction in emphysema
|
PETRACHE, IRINA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$269,481
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL079328-04
|
|
Preotease/Cathepsin-Mediated Apoptosis in COPD
|
ELIAS, JACK
|
YALE UNIVERSITY
|
CT
|
$387,569
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL079077-04
|
|
Improved Methods for Hyperpolarized-Gas MRI of the Lung
|
MUGLER, JOHN
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$420,396
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL079406-03
|
|
Regional Lung Mechanics by 3D Image Registration
|
REINHARDT, JOSEPH
|
UNIVERSITY OF IOWA
|
IA
|
$319,483
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5K01HL084675-03
|
|
The Pathobiology of Airway Disease in Alpha-1 Antitrypsin Deficiency
|
CAMPOS, MICHAEL
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$132,597
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5K08HL080242-04
|
|
Fine Mapping of a COPD Locus on Chromosome 19q
|
HERSH, CRAIG
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$133,633
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5K23RR020632-04
|
|
The Molecular Basis of Familial Spontaneous Pneumothorax
|
GARCIA, CHRISTINE
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$151,200
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R15HL092536-01
|
|
AREA Program: In Vitro Modeling of Smoke Induced Loss of Lung Barrier Function
|
KNALL, CINDY
|
UNIVERSITY OF ALASKA ANCHORAGE
|
AK
|
$197,652
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL085655-01A2
|
|
Role of Metalloproteinases in Mucin Overproduction in COPD
|
LEIKAUF, GEORGE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$353,187
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
2R01HL065503-06A1
|
|
Telephone-based coping skills training for COPD
|
BLUMENTHAL, JAMES
|
DUKE UNIVERSITY
|
NC
|
$748,353
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL082480-04
|
|
Innate and adaptive immunity in COPD exacerbations
|
CURTIS, JEFFREY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$580,697
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL082550-04
|
|
Rhinovirus and COPD exacerbations
|
HERSHENSON, MARC
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$345,389
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL082487-04
|
|
Viral-induced T Cell Responses in COPD Exacerbation
|
KHERADMAND, FARRAH
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$626,109
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL082504-04
|
|
Mucin Gene Regulation by Elastase and Oxidants
|
VOYNOW, JUDITH
|
DUKE UNIVERSITY
|
NC
|
$295,832
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1K08HL089135-01A1
|
|
Role of Werner's Syndrome Protein in Cigarette Smoke-Induced Cellular Senescence
|
NYUNOYA, TORU
|
UNIVERSITY OF IOWA
|
IA
|
$126,387
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5K23HL077660-05
|
|
Mechanisms of gland proliferation in COPD
|
HAYS, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$148,770
|
Chronic Obstructive Pulmonary Disease
|
NIEHS
|
1R21ES015781-01A1
|
|
Domestic endotoxin exposure and chronic obstructive pulmonary disease
|
HANSEL, NADIA
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$246,000
|
Chronic Obstructive Pulmonary Disease
|
NCI
|
1K07CA125203-01A2
|
|
Exploring Common Linkage Regions in Lung Cancer and COPD
|
COTE, MICHELE
|
WAYNE STATE UNIVERSITY
|
MI
|
$132,921
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL082505-04
|
|
Induction of COPD Exacerbation by Haemophilus influenzae
|
LOOK, DWIGHT
|
UNIVERSITY OF IOWA
|
IA
|
$314,678
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL082541-05
|
|
Genetic and Environmental Factors Affecting COPD Exacerbations
|
SHAPIRO, STEVEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$713,287
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL054853-13
|
|
Electrophil elastase in lung cancer and COPD
|
SHAPIRO, STEVEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$360,484
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL082561-04
|
|
Innate Immunity and exacerbations of COPD
|
SETHI, SANJAY
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$392,941
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R21HL089525-01A1
|
|
Very-short-time diffusion MRI of hyperpolarized gases
|
MILLER, G.
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$183,007
|
Chronic Obstructive Pulmonary Disease
|
NIDCR
|
5U01DE017788-03
|
|
Microsensor Arrays for Saliva Diagnostics
|
WALT, DAVID
|
TUFTS UNIVERSITY MEDFORD
|
MA
|
$1
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL089064-01A1
|
|
Quantitative Structural and Functional Imaging of the Lung
|
RIZI, RAHIM
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$653,301
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R21HL089431-01A1
|
|
Systems approach to identify phosphoregulators of mouse lung development
|
NISWANDER, LEE
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$230,566
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
2R01HL077241-05
|
|
Imaging regional physiologic parameters of lung function
|
RIZI, RAHIM
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$365,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1K01HL092601-01
|
|
Genetic Analysis of Susceptibility to COPD Exacerbations
|
FOREMAN, MARILYN
|
MOREHOUSE SCHOOL OF MEDICINE
|
GA
|
$141,993
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
2R01HL073156-05A1
|
|
MECHANISMS OF OXIDANT-INDUCED CHRONIC BRONCHITIS
|
FORTEZA, ROSANNA
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$306,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL067438-07
|
|
Disability in Valued Life Activities in COPD
|
KATZ, PATRICIA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$497,599
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5K08HL085286-03
|
|
Interrelationships Between COPD, Inflammation, and Lung Tumorigenesis
|
HOUGHTON, A
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$126,225
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
2R42HL082013-02A2
|
|
Hyperpolarized xenon functional MRI of human lung microstructure
|
RUSET, IULIAN
|
XEMED, LLC
|
NH
|
$380,764
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL090999-02
|
|
Effect of Macrolide Treatment on a Novel Pathway of Neutrophilic Inflammation in
|
BLALOCK, J.
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$362,500
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL085312-02
|
|
The Role of Hepatocyte Growth Factor Signaling Airspace Homeostasis
|
NEPTUNE, ENID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$410,000
|
Chronic Obstructive Pulmonary Disease
|
NINR
|
5R01NR010249-02
|
|
Nurse Managed: Sequential Resistance then Aerobic Training in COPD
|
COVEY, MARGARET
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$444,515
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
2R44EB007439-02
|
|
Production, validation, and commercialization of MagniLium (hyperpolarized 3He)
|
WATT, DAVID
|
XEMED, LLC
|
NH
|
$454,815
|
Chronic Obstructive Pulmonary Disease
|
NIBIB
|
2R44EB007439-02
|
|
Production, validation, and commercialization of MagniLium (hyperpolarized 3He)
|
WATT, DAVID
|
XEMED, LLC
|
NH
|
$3
|
Chronic Obstructive Pulmonary Disease
|
NCI
|
7K23CA106544-05
|
|
Pulmonary rehabilitation before lung cancer resection.
|
BENZO, ROBERTO
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$133,650
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL090927-02
|
|
Oxidative Stress and Anti-Inflammatory Lipids in Airway Disease
|
LEVY, BRUCE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$437,500
|
Chronic Obstructive Pulmonary Disease
|
NIEHS
|
5R01ES015036-03
|
|
Shared Mechanisms of Pulmonary Lymphocyte Activation by Bacteria and Toxicants
|
BORCHERS, MICHAEL
|
UNIVERSITY OF CINCINNATI
|
OH
|
$382,473
|
Chronic Obstructive Pulmonary Disease
|
NIAID
|
5R44AI043789-07
|
|
Preclinical Development of LIGO-069-136, An Anti-Inflammatory Pulmonary Therapeut
|
BARGATZE, ROBERT
|
LIGOCYTE PHARMACEUTICALS, INC.
|
MT
|
$1,547,235
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1SC1HL096016-01
|
|
Plant Polyphenols for the Treatment of Chronic Obstructive Pulmonary Disease
|
KENNELLY, EDWARD
|
HERBERT H. LEHMAN COLLEGE
|
NY
|
$285,250
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL090145-02
|
|
Pneumografting - a novel cell-based therapy for emphysema
|
INGENITO, EDWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$581,083
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL090339-02
|
|
Prevalence & Pathogenesis of Pulmonary Disease in a Large Multicenter HIV Cohort
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$829,058
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL075415-06
|
|
CAMP Continuation Study/Phase 3
|
ZEIGER, ROBERT
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$181,819
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL075232-06
|
|
CAMP Continuation Study/Phase 3
|
STRUNK, ROBERT
|
WASHINGTON UNIVERSITY
|
MO
|
$165,918
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL075420-06
|
|
CAMP Continuation Study/Phase 3
|
KELLY, H
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$146,552
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL090483-02
|
|
The Study of HIV Infection in the Etiology of Lung Disease (SHIELD)
|
KIRK, GREGORY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$890,479
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL075407-06
|
|
CAMP Continuation Study/Phase 3
|
GRASEMANN, HARTMUT
|
HOSPITAL FOR SICK CHLDRN (TORONTO)
|
CANADA
|
$129,605
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL090313-02
|
|
Smoking cessation and the natural history of HIV-associated emphysema
|
DIAZ, PHILIP
|
OHIO STATE UNIVERSITY
|
OH
|
$739,322
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL075417-06
|
|
CAMP Continuation Study/Phase 3
|
ADKINSON, N
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$179,526
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL075409-06
|
|
CAMP Continuation Study/Phase 3
|
WILLIAMS, PAUL
|
ASTHMA, INC.
|
WA
|
$195,242
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL075416-06
|
|
CAMP Contiunation Study/Phase 3
|
SZEFLER, STANLEY
|
NATIONAL JEWISH HEALTH
|
CO
|
$163,055
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL075419-06
|
|
CAMP Continuation Study/Phase 3
|
FUHLBRIGGE, ANNE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$272,174
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL075408-06
|
|
CAMPCS/3
|
TONASCIA, JAMES
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$532,063
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R01HL084323-02
|
|
Genetic Determinants of COPD in Diverse Ethnic Groups
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$771,391
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL089897-02
|
|
Genetic Epidemiology of COPD
|
CRAPO, JAMES
|
NATIONAL JEWISH HEALTH
|
CO
|
$7,227,714
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5U01HL089856-02
|
|
Genetic Epidemiology of COPD
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$892,773
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL093081-01
|
|
Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary Disease (COPD)
|
BARR, R
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$788,314
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5R21HL087274-02
|
|
Mechanisms of Marrow-Derived Stem Cell Remodeling of Aged Emphysematous Lungs
|
WEISS, DANIEL
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$228,000
|
Chronic Obstructive Pulmonary Disease
|
NHGRI
|
1U01HG004738-01
|
|
Genome-Wide Associations Environmental Interactions in the Lung Health Study
|
BARNES, KATHLEEN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$590,469
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL088192-01A2
|
|
Pulmonary Vasoreactivity Following Chronic Hypoxia
|
RESTA, THOMAS
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$375,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL087001-01A2
|
|
Pathophysiology of PPARgamma in the lung
|
DU, HONG
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$375,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL086631-01A2
|
|
Mechanical Ventilation of Newborn Mice:Impact on Alveolarization and Lung Elastin
|
BLAND, RICHARD
|
STANFORD UNIVERSITY
|
CA
|
$452,689
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL090806-01A1
|
|
EVALUATION OF ENDOBRONCHIAL INTERVENTIONS FOR COPD VIA CT AND 3HE MRI
|
WOODS, JASON
|
WASHINGTON UNIVERSITY
|
MO
|
$395,368
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL090950-01A1
|
|
EMAP II, a molecular link of inflammation and apoptosis in pulmonary emphysema.
|
CLAUSS, MATTHIAS
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$368,800
|
Chronic Obstructive Pulmonary Disease
|
NCCAM
|
1R01AT004793-01
|
|
Quercetin and Innate Immune Responses in COPD
|
SAJJAN, UMADEVI
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$373,957
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1K23HL091049-01A1
|
|
The Social Environment, Psychological Distress, and Clinical Outcomes in COPD
|
HOLM, KRISTEN
|
NATIONAL JEWISH HEALTH
|
CO
|
$132,178
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1K08HL081270-01A2
|
|
Membrane-type 1 Matrix Metalloproteinase in COPD
|
ATKINSON, JEFFREY
|
WASHINGTON UNIVERSITY
|
MO
|
$123,800
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1K08HL091127-01A1
|
|
Biology of Leukotrienes in the Pathogenesis of Emphysema
|
SHIM, YUN
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$128,697
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R21HL091351-01A1
|
|
Development of Hyperpolarized Helium for Assessing ILD
|
ROSSMAN, MILTON
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$236,250
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1K25HL091124-01A1
|
|
A Developmental Basis for Chronic Obstructive Lung Disease
|
KHO, ALVIN
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$148,500
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1K08HL091058-01A1
|
|
Role of Regulatory T Cells in Chronic Obstructive Pulmonary Disease
|
CHATILA, WISSAM
|
TEMPLE UNIVERSITY
|
PA
|
$134,500
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1K23HL089353-01A1
|
|
Using Computed Tomographic Imaging as a biomarker for Clinical COPD Research
|
WASHKO, GEORGE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$142,560
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1F32HL094035-01
|
|
Systematic Review and Meta-Analysis of COPD Genetic Studies
|
CASTALDI, PETER
|
TUFTS MEDICAL CENTER
|
MA
|
$71,006
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1F32HL094018-01
|
|
A novel intervention strategy for emphysema by targeting the Nrf2 pathway
|
BLAKE, DAVID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$47,306
|
Chronic Obstructive Pulmonary Disease
|
NIEHS
|
5R21ES014372-02
|
|
SERPINE2 as a Candidate COPD Susceptibility Gene
|
MARIANI, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$166,355
|
Chronic Obstructive Pulmonary Disease
|
NIEHS
|
5P30ES013508-03
|
9003
|
CORE--Lung and Airway Disease
|
PANETTIERI, REYNOLD
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$88,319
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P01HL010342-41
|
0038
|
Genetic Basis of Lung Elasticity and Structure
|
TANKERSLEY, CLARKE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$319,681
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R03HL095370-01
|
|
Defining the Role of Pneumocystis in COPD Pathogenesis
|
MORRIS, ALISON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$75,750
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL095382-01
|
|
Molecular Phenotypes for Lung Diseases
|
CORRY, DAVID
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$697,014
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL095397-01
|
|
Molecular Phenotypes within and across disease boundaries in IPF and COPD
|
KAMINSKI, NAFTALI
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$770,981
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
7R01HL071690-06
|
|
Evaluation of Home Automated Telemanagement in COPD
|
FINKELSTEIN, JOSEPH
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$613,730
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R01HL095388-01
|
|
Linking airway genomics to the pathogenesis and clinical heterogeneity of COPD
|
SPIRA, AVRUM
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$760,175
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R03HL095406-01
|
|
Tissue-based validation of COPD Genetic Studies using Lung Health Study Cohort
|
NEPTUNE, ENID
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$82,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R03HL095404-01
|
|
Redox Biology in COPD
|
JANSSEN-HEININGER, YVONNE
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
VT
|
$75,250
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R03HL095407-01
|
|
PLAGL2 Expression in Emphysema Patient Lungs
|
YANG, YIH-SHENG
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$78,500
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R03HL095403-01
|
|
Adenosine Metabolism and Signaling in Patients and COPD and Pulmonary Fibrosis
|
BLACKBURN, MICHAEL
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$75,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R03HL095420-01
|
|
Regulation of Nrf2 pathway during COPD pathogenesis
|
BISWAL, SHYAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$82,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R03HL095440-01
|
|
Signaling Sphingolipids in COPD
|
BERDYSHEV, EVGENY
|
UNIVERSITY OF CHICAGO
|
IL
|
$84,854
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R03HL095425-01
|
|
Integration of transcriptosome and microRNome in Understanding COPD Phenotypes
|
NANA-SINKAM, SERGE
|
OHIO STATE UNIVERSITY
|
OH
|
$75,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R03HL095439-01
|
|
Selected Peptidases and Pulmonary Vascular Remodeling in Chronic Obstructive Pulm
|
DEMPSEY, EDWARD
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$76,979
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
1R03HL095450-01
|
|
The Unfolded Protein Response in Subjects with COPD
|
KELSEN, STEVEN
|
TEMPLE UNIVERSITY
|
PA
|
$75,000
|
Chronic Obstructive Pulmonary Disease
|
NIAID
|
1R56AI069379-01A2
|
|
Innate and adaptive immune response to bacterial infections in COPD patients
|
THANAVALA, YASMIN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$398,735
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
3U10HL074424-05S1
|
|
COPD Clinical Research Network - Data Coordinating Cent*
|
CONNETT, JOHN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$3,400,000
|
Chronic Obstructive Pulmonary Disease
|
OD
|
5U54ES015678-03
|
0001
|
Thiols in sulfur mustard toxicity
|
WHITE, CARL
|
NATIONAL JEWISH HEALTH
|
CO
|
$358,174
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084934-03
|
0002
|
ASL volume and innate defense in CF and COPD Airways
|
TARRAN, ROBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$459,774
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084934-03
|
0004
|
Mucus Dehydration and Evolution of COPD Lung Disease
|
BOUCHER, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$487,846
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
3R01HL090145-02S1
|
|
Pneumografting - a novel cell-based therapy for emphysema
|
INGENITO, EDWARD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$21,000
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P01HL075161-04
|
0003
|
Marrow Stromal Cell Homing to the Lung in Emphysema
|
SHELLITO, JUDD
|
TULANE UNIVERSITY OF LOUISIANA
|
LA
|
$437,494
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084945-02
|
0001
|
Novel Protective Antiapoptotic Action of Alpha 1-Antitrypsin In Emphysema
|
TUDER, RUBIN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$466,958
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084945-02
|
0002
|
Novel Treatments to Prevent COPD Progression
|
WISE, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$568,708
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084945-02
|
0003
|
Sleep Related Mechanisms of COPD Progression
|
SCHWARTZ, ALAN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$525,885
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084945-02
|
0004
|
Oxidative Insult and Susceptibility of Developing Lungs to Emphysema
|
BISWAL, SHYAM
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$325,522
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084945-02
|
9001
|
Imaging Core
|
BROWN, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$266,220
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084945-02
|
9003
|
MOLECULAR PATHOPHYSIOLOGY CORE
|
TUDER, RUBIN
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$252,438
|
Chronic Obstructive Pulmonary Disease
|
NCI
|
3R01CA127219-01A1S1
|
|
Inflammation Genes and Lung Cancer Risk
|
SPITZ, MARGARET
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$399,774
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P01HL083069-02
|
0001
|
Genetic Association in Human Asthma Populations
|
WEISS, SCOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$132,168
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P01HL083069-02
|
0002
|
Genetic Association Studies in Human COPD Populations
|
SILVERMAN, EDWIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$77,382
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P01HL083069-02
|
0003
|
Genetics of Asthma and COPD
|
SHAPIRO, STEVEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$962,212
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084922-02
|
0001
|
Detection: Lung Imaging and Profiling
|
PIERCE, RICHARD
|
WASHINGTON UNIVERSITY
|
MO
|
$437,499
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084922-02
|
0002
|
Genetic Determinants: Elastin Quality and Quantity
|
MECHAM, ROBERT
|
WASHINGTON UNIVERSITY
|
MO
|
$403,867
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084922-02
|
0003
|
Alveolar Determinants: MMPs and Emphysema
|
SENIOR, ROBERT
|
WASHINGTON UNIVERSITY
|
MO
|
$456,301
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084922-02
|
0004
|
Airway Determinants: Innate Immune Signaling
|
HOLTZMAN, MICHAEL
|
WASHINGTON UNIVERSITY
|
MO
|
$543,444
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084922-02
|
9001
|
Registry And Data Analysis
|
YUSEN, ROGER
|
WASHINGTON UNIVERSITY
|
MO
|
$169,894
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084922-02
|
9002
|
Imaging
|
GIERADA, DAVID
|
WASHINGTON UNIVERSITY
|
MO
|
$203,900
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084922-02
|
9003
|
Morphology and Microscopy
|
WALTER, MICHAEL
|
WASHINGTON UNIVERSITY
|
MO
|
$163,921
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084936-02
|
0001
|
Role of Alveolar Macrophages in the Accelerated Emphysema of HIV-1 Positive
|
KANER, ROBERT
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$290,365
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084936-02
|
0002
|
Derangements of the Notch Pathway in Airway Epithelial Differentiation in COPD
|
HACKETT, NEIL
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$490,842
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084936-02
|
0003
|
Contribution of CXCR4+VEGFR1+ Hemangiogenic Progenitors to Lung Revascularization
|
RAFII, SHAHIN
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$411,594
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084936-02
|
0004
|
Dysregulation of Ciliogenesis in the Ariway Epithelium in COPD
|
CRYSTAL, RONALD
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$395,370
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084936-02
|
9004
|
CORE--Cell Biology / Morphology
|
LEOPOLD, PHILIP
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$197,445
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084948-02
|
0001
|
Peripheral Markers of Phenotypic Heterogeneity in COPD
|
SCIURBA, FRANK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$807,934
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084948-02
|
0002
|
Adaptive Immune-Induced Airway Injury in COPD
|
HOGG, JAMES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$501,783
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084948-02
|
0003
|
Clinical Investigation of Aerosol Immunotherapy in COPD
|
DONAHOE, MICHAEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$305,414
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084948-02
|
9001
|
Clinical
|
SCIURBA, FRANK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$367,883
|
Chronic Obstructive Pulmonary Disease
|
NHLBI
|
5P50HL084948-02
|
9004
|
Administrative
|
SCIURBA, FRANK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$139,247
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
2M01RR000046-48
|
6948
|
CLINICAL TRIAL: MUCUS CLEARANCE AND EVOLUTION OF COPD LUNG DISEASE
|
BOUCHER, RICHARD
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$5,509
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR000065-46
|
7171
|
FACTORS AFFECTING ORAL SELF-CARE IN COPD: A FEASIBILITY STUDY
|
BOYLE, ANNE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$379
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR000082-46
|
7211
|
CLINICAL TRIAL: TOBACCO SMOKE INDUCED CELL INJURY IN LUNG COMPARTMENTS
|
BRANTLY, MARK
|
UNIVERSITY OF FLORIDA
|
FL
|
$24,930
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR000082-46
|
7212
|
CLINICAL TRIAL: PHASE I TRIAL OF INTRAMUSCULAR INJECTION OF RAAV1-CB-HAAT
|
BRANTLY, MARK
|
UNIVERSITY OF FLORIDA
|
FL
|
$26,556
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR000082-46
|
7254
|
ALPHA-1 ANTITRYPSIN AND MACROPHAGE FUNCTION
|
BRANTLY, MARK
|
UNIVERSITY OF FLORIDA
|
FL
|
$9,756
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR000425-39
|
7418
|
ANTI-LEUKOTRIENE THERAPY FOR COPD EXACERBATIONS
|
CASABURI, RICHARD
|
LA BIOMED RES INST/ HARBOR UCLA MED CTR
|
CA
|
$1,463
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR000188-44
|
7860
|
VIRAL-INDUCED T CELL RESPONSES IN COPD EXACERBATION PROTOCOL: LES COPD
|
KHERADMAND, FARRAH
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$49,078
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR008084-15
|
7951
|
QUANTITATIVE CHEST COMPUTED TOMOGRAPHY IN ALPHA-1-ANTITRYPSIN DEFICIENCY
|
TRAPNELL, BRUCE
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$520
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR016500-07
|
8168
|
COLLECTION OF BLOOD FOR FUTURE GENETIC TESTING
|
SCHARF, STEVEN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$4,532
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR016500-07
|
8181
|
CLINICAL TRIAL: EFFECT OF CHRONIC MACROLIDE ADMINISTRATION ON COPD EXACERBATIONS
|
SCHARF, STEVEN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$114,803
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR016500-07
|
8203
|
CLINICAL TRIAL: PNEUMOCOCCAL VACCINE RESPONSE IN COPD
|
SCHARF, STEVEN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$24,672
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR016500-07
|
8207
|
CLINICAL TRIAL: ANTI-LEUKOTRIENE THERAPY FOR COPD EXACERBATIONS
|
SCHARF, STEVEN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$4,029
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR007122-17
|
8328
|
CLINICAL TRIAL: GENE POLYMORPHISMS AND INTERVENTIONS TO PREVENT DISABILITY IN CO
|
BERRY, MICHAEL
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$516
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR000034-48
|
8748
|
ALVEOLAR MACROPHAGE PROTEOMICS IN HIV-ASSOCIATED EMPHYSEMA
|
DIAZ, PHILIP
|
OHIO STATE UNIVERSITY
|
OH
|
$299,018
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR001346-27
|
8844
|
BRONCHITIS AND EMPHYSEMA ADVICE AND TRAINING TO REDUCE HOSPITALIZATION
|
ADAMS, SANDRA
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$1,649
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR001032-33
|
5160
|
CLINICAL TRIAL: MIND-BODY EXERCISE FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE: PI
|
YEH, GLORIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$1,337
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR000051-47
|
5600
|
RISK FACTORS FOR THE DEVELOPMENT OF COPD IN SMOKERS
|
BOWLER, RUSSELL
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$3,243
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR000051-47
|
5604
|
CLINICAL TRIAL: EFFECT OF CHRONIC MACROLIDE ADMINISTRATION ON COPD EXACERBATIONS
|
ALBERT, RICHARD
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$6,407
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5M01RR000051-47
|
5736
|
EFFECT OF CHRONIC MACROLIDE ADMIN ON THE FREQNCY & SEVERTY OF COPD EXACERBATIONS
|
ALBERT, RICHARD
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$3,401
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5P20RR011104-14
|
6760
|
COPD GENE STUDY
|
FOREMAN, MARILYN
|
MOREHOUSE SCHOOL OF MEDICINE
|
GA
|
$136,619
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
5P41RR002305-24
|
6051
|
VALIDATION OF REGIONAL COMPLIANCE OF LUNG MEASUREMENT
|
STEPHEN, MICHAEL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$21,755
|
Chronic Obstructive Pulmonary Disease
|
NCRR
|
2P41RR005959-19
|
7763
|
HOST DEFENSE MECHANISMS IN CHRONIC LUNG DISEASE
|
PALMER, SCOTT
|
DUKE UNIVERSITY
|
NC
|
$6,473
|
Chronic Obstructive Pulmonary Disease
|
NCI
|
1Z01CP010120-13
|
|
Studies of Occupational Cancer
|
HAYES, RICHARD
|
NIH
|
|
$4,308,955
|
Chronic Obstructive Pulmonary Disease
|
NIEHS
|
1Z01ES043012-10
|
|
Genetic And Environmental Factors In Adult Respiratory and Cardiac Disease
|
LONDON, STEPHANIE
|
NIH
|
|
$128,041
|